Where is the live CopyMark page for USPTO serial 79054097?

The live record is at https://getcopymark.com/trademark/79054097. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns NNE PHARMAPLAN?

According to the public USPTO record for serial number 79054097, the listed owner(s) include: NNE A/S, NNE Pharmaplan A/S, NNE Pharmaplan A/S.

What is USPTO serial number 79054097?

Serial number 79054097 is the USPTO application identifier for the mark NNE PHARMAPLAN. It is used to track examination, publication, and registration of this trademark.

What is the current status of NNE PHARMAPLAN?

NNE PHARMAPLAN (79054097) currently shows USPTO status code 709 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover NNE PHARMAPLAN?

The public record lists International Classes: 035, 036, 037, 041, 042. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: NNE PHARMAPLAN Serial# 79054097 | status 709; last event NREP | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NNE PHARMAPLAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia A. Smith

Claudia A. Smith White & Case LLP1155 AVE OF THE AMERICASTrademark DepartmentNew York, NY 10036

Goods and services

Class	Description	Status	First use
035	Business management consultancy as well as development of processes for the analysis and implementation of strategy plans and management projects in the pharmaceutical and biotechnical industries including for healthcare and for hospitals	SECTION 71 - CANCELLED	—
036	Financial consultations in the fields of planning and producing and construction of medical and biotechnical installations; financial services, namely, risk evaluations, namely, financial risk management	SECTION 71 - CANCELLED	—
037	Construction activities, namely, construction of medical and biotechnical installations, research laboratories and hospitals	SECTION 71 - CANCELLED	—
041	Providing educational training courses in the field of goods manufacturing practices for the production of pharmaceutical and biotechnical products	SECTION 71 - CANCELLED	—
042	Engineering consultancy, consultancy in architecture and environmental planning, including consultancy in the planning of pharmaceutical and biotechnical industries, related industries and hospitals; engineering services in the fields of plant engineering, ventilation, heating and technical engineering all in the pharmaceutical and biotechnological field	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jan 7, 2023	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Jan 9, 2022	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Dec 16, 2021	INTS	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Dec 16, 2021	INPC	INVALIDATION PROCESSED	—
Oct 26, 2021	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Feb 26, 2021	C71T	CANCELLED SECTION 71	—
Mar 30, 2019	REM4	COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED	—
Oct 18, 2018	ADCH	CHANGE OF NAME/ADDRESS REC'D FROM IB	—
Jan 25, 2018	RNWL	INTERNATIONAL REGISTRATION RENEWED	—
Jul 27, 2017	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
May 2, 2016	NA71	NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED	—
May 2, 2016	71AG	REGISTERED-SEC.71 ACCEPTED	—
Apr 18, 2016	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
Feb 26, 2016	ES71	TEAS SECTION 71 RECEIVED	—
Mar 22, 2013	ADCH	CHANGE OF NAME/ADDRESS REC'D FROM IB	—
Feb 5, 2013	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Jul 15, 2010	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Jul 15, 2010	FIMP	FINAL DISPOSITION PROCESSED	—
Jun 30, 2010	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Mar 30, 2010	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 12, 2010	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Jan 12, 2010	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2009	OPNX	NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB	—
Dec 7, 2009	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Dec 7, 2009	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Nov 26, 2009	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
Nov 26, 2009	OPNR	NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB	—
Nov 16, 2009	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Nov 16, 2009	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Nov 16, 2009	ERFR	TEAS REQUEST FOR RECONSIDERATION RECEIVED	—
Nov 16, 2009	TCCA	TEAS CHANGE OF CORRESPONDENCE RECEIVED	—
Aug 20, 2009	CNFR	FINAL REFUSAL MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 19, 2009	CNFR	FINAL REFUSAL WRITTEN	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 31, 2009	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Jul 31, 2009	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jul 28, 2009	MAIL	PAPER RECEIVED	—
Feb 3, 2009	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2009	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2009	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jan 8, 2009	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jan 7, 2009	ALIE	ASSIGNED TO LIE	—
Dec 22, 2008	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 25, 2008	RFNT	REFUSAL PROCESSED BY IB	—
Jul 3, 2008	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Jul 3, 2008	RFRR	REFUSAL PROCESSED BY MPU	—
Jul 3, 2008	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Jul 2, 2008	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2008	DOCK	ASSIGNED TO EXAMINER	—
Jun 27, 2008	NWAP	NEW APPLICATION ENTERED	—
Jun 26, 2008	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

NNE PHARMAPLAN